Compare JOB & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JOB | MODD |
|---|---|---|
| Founded | 1893 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2M | 23.5M |
| IPO Year | 2021 | 2019 |
| Metric | JOB | MODD |
|---|---|---|
| Price | $0.23 | $4.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 171.9K | 16.1K |
| Earning Date | 05-14-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.62 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $96,504,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $0.12 |
| 52 Week High | $0.28 | $6.16 |
| Indicator | JOB | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 43.70 | 53.63 |
| Support Level | $0.22 | $4.41 |
| Resistance Level | $0.26 | $5.89 |
| Average True Range (ATR) | 0.01 | 0.58 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 19.00 | 58.04 |
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.